Imunon Inc (NASDAQ: IMNN)’s stock price has dropped by -16.79 in relation to previous closing price of 1.37. Nevertheless, the company has seen a loss of -21.38% in its stock price over the last five trading days. GlobeNewsWire reported 2024-03-21 that LAWRENCEVILLE, N.J., March 21, 2024 (GLOBE NEWSWIRE) — IMUNON, Inc. (NASDAQ: IMNN), a clinical-stage drug-development company focused on developing DNA-mediated immunotherapy and next-generation vaccines, announces that the Company will host a conference call at 10:00 a.m. ET on Thursday, March 28, 2024 to discuss financial results for the year ended December 31, 2023 and provide an update on its clinical development programs with IMNN-001, a DNA-based interleukin-12 (IL-12) immunotherapy in Phase 2 clinical development for the treatment of first-line, locally advanced-stage ovarian cancer, and on its PlaCCine modality, a proprietary mono- or multi-cistronic DNA plasmid and a synthetic DNA delivery technology for the expression of pathogen antigens in preclinical studies for the development of next-generation vaccines.
Is It Worth Investing in Imunon Inc (NASDAQ: IMNN) Right Now?
IMNN has 36-month beta value of 2.03. Analysts have mixed views on the stock, with 0 analysts rating it as a “buy,” 0 as “overweight,” 0 as “hold,” and 0 as “sell.”
The public float for IMNN is 9.34M, and currently, short sellers hold a 4.75% ratio of that float. The average trading volume of IMNN on April 18, 2024 was 219.25K shares.
IMNN’s Market Performance
IMNN stock saw an increase of -21.38% in the past week, with a monthly gain of 38.18% and a quarterly increase of 77.57%. The volatility ratio for the week is 11.75%, and the volatility levels for the last 30 days are 16.24% for Imunon Inc (IMNN). The simple moving average for the past 20 days is -15.41% for IMNN’s stock, with a 14.78% simple moving average for the past 200 days.
IMNN Trading at 16.32% from the 50-Day Moving Average
After a stumble in the market that brought IMNN to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -43.00% of loss for the given period.
Volatility was left at 16.24%, however, over the last 30 days, the volatility rate increased by 11.75%, as shares surge +41.44% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +119.02% upper at present.
During the last 5 trading sessions, IMNN fell by -21.38%, which changed the moving average for the period of 200-days by -11.63% in comparison to the 20-day moving average, which settled at $1.3644. In addition, Imunon Inc saw 67.65% in overturn over a single year, with a tendency to cut further gains.
Stock Fundamentals for IMNN
The total capital return value is set at -1.45. Equity return is now at value -91.37, with -59.23 for asset returns.
Based on Imunon Inc (IMNN), the company’s capital structure generated 0.11 points at debt to capital in total, while cash flow to debt ratio is standing at -11.71. The debt to equity ratio resting at 0.12. The interest coverage ratio of the stock is -106.7.
Currently, EBITDA for the company is -20.31 million with net debt to EBITDA at 0.21. The liquidity ratio also appears to be rather interesting for investors as it stands at 2.47.
Conclusion
To put it simply, Imunon Inc (IMNN) has had a mixed performance in recent times. Analysts have a mixed opinion on the stock, with some rating it as a “buy” and others as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
